NIH Selects Northwell to Join Diabetic Foot Ulcer Consortium

Northwell Health has been selected to join the Diabetic Foot Consortium as a satellite site and awarded a grant by the National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK).

The Diabetic Foot Consortium is led by a network of seven universities with satellite locations all working to drive clinical research. Northwell will serve as a satellite program and collaborate directly with the University of Michigan team. The NIDDK is part of the National Institutes of Health (NIH), the nation’s medical research agency.

Northwell’s $50,000 NIH grant will go toward refining wound care best practices and equity of care in the diabetic population. An estimated 37 million Americans are living with diabetes – many of them undiagnosed – and diabetic foot disease is a key factor that accounts for a measurable reduction in life expectancy.

“Diabetic foot ulcers are the leading cause of lower limb amputations in the United States today, which is why we’re excited to be part of the solution to such a chronic health problem,” said Alisha Oropallo, MD, a vascular surgeon and director of the Comprehensive Wound Healing Center and Hyperbarics at Northwell Health. “As a satellite member of the Diabetic Foot Consortium, Northwell will be able to conduct studies and tap into research to improve the lives of New Yorkers living with diabetic foot ulcers.”

Northwell’s Comprehensive Wound Healing Center and Hyperbarics, located at 1999 Marcus Ave., Suite M6, in Lake Success, NY, specializes in diabetic wound care. The center features a state-of-the-art vascular lab, a New York State-licensed tissue bank and diagnostic imaging that can assess microperfusion.

For more information or to make an appointment, call 516-233-3780.

Hot this week

Avery Dennison Medical Introduces Ipdated SilFoam Lite: Sustainability, MDR Certification & Performance Improvements

The newly enhanced SilFoam Lite delivers superior efficiency and reliability, bringing improved fluid handling capabilities and improved tack. These improvements make the product ideal for customers seeking quality, high-performance solutions in wound care notes Avery Dennison Medical.

Voluntary Recall Notifying Medtronic Insulin Pump Users of Potential Risks of Shortened Pump Battery Life

Medtronic plc voluntarily issued a field action starting on July 31, 2024, notifying global customers of its MiniMed™ 600 series or 700 series insulin pumps to follow their pump's built-in alerts and alarms for battery status and to contact Medtronic if they observe changes in the battery life of their pump

Medtronic Expands AiBLE Spine Surgery Ecosystem with New Technologies and Siemens Healthineers Partnership

New advancements in the AiBLE Spine Surgery ecosystem build upon the company's commitment to procedural innovation and execution

Axlab, Danish Medtech Pioneer, expands to US with Advanced Robotic Tissue Sectioning for Pathology Laboratories

Kris Rokke, National Sales Director for Axlab in the US. "My team and I are extremely excited and honored about this unique opportunity to also offer this advanced technology to labs across the US and thus contribute to the pathology labs of tomorrow."

Spartan Medical Broadens Single-Use Sterile Instrument Portfolio to Improve Outcomes, Increase Efficiency, and Generate Cost Savings

Spartan Medical products portfolio of single-use, sterile med tech includes micro and minor surgical convenience kits, kerrison rongeurs, spinal and general surgical retractors, dural repair kits, synthetic biologics, and a wide range of orthopedic pre-sterilized implants and devices.